Elarcosa, Mary Grace .
HRN: 01-16-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/18/2026
AMPICILLIN 1GM (VIAL)
07/18/2026
07/20/2026
IVT
2g
Q6 Anst
Prom
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes